Human Genome Epidemiology Literature Finder
Records 1 - 29 (of 29 Records) |
Query Trace: Arthritis and ABCG2[original query] |
---|
ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases. Scandinavian journal of gastroenterology 2007 Jun 42 (6): 726-33. Fischer Simon, Lakatos Peter Laszlo, , Lakatos Laszlo, Kovacs Agota, Molnar Tamas, Altorjay Istvan, Papp Maria, Szilvasi Aniko, Tulassay Zsolt, Osztovits Janos, Papp Janos, Demeter Pal, Schwab Richard, Tordai Attila, Andrikovics Hajnal |
Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Science translational medicine 2009 Nov 1 (5): 5. Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Ikebuchi Y, Ito K, Kusanagi Y, Chiba T, Tadokoro S, Takada Y, Oikawa Y, Inoue H, Suzuki K, Okada R, Nishiyama J, Domoto H, Watanabe S, Fujita M, Morimoto Y, Naito M, Nishio K, Hishida A, Wakai K, Asai Y, Niwa K, Kamakura K, Nonoyama S, Sakurai Y, Hosoya T, Kanai Y, Suzuki H, Hamajima N, Shinomiya N |
Polymorphisms within the folate pathway predict folate concentrations but are not associated with disease activity in rheumatoid arthritis patients on methotrexate. Pharmacogenetics and genomics 2010 Jun 20 (6): 367-76. Stamp Lisa K, Chapman Peter T, O'Donnell John L, Zhang Mei, James Jill, Frampton Christopher, Barclay Murray L, Kennedy Martin A, Roberts Rebecca |
Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis. Drug metabolism and pharmacokinetics 2012 27 (2): 192-9. Kato Tomomi, Hamada Akinobu, Mori Shunsuke, Saito Hideyu |
Polymorphisms in cytochrome P450 2C19 enzyme and cessation of leflunomide in patients with rheumatoid arthritis. Arthritis research & therapy 2012 14 (4): R163. Wiese Michael D, Schnabl Matthew, O'Doherty Catherine, Spargo Llewellyn D, Sorich Michael J, Cleland Leslie G, Proudman Susanna |
Leflunomide for inflammatory arthritis in end-stage renal disease on peritoneal dialysis: a pharmacokinetic and pharmacogenetic study. The Annals of pharmacotherapy 2013 Mar 47 (3): e15. Russo Paul A J, Wiese Michael D, Smith Malcolm D, Ahern Michael J, Barbara Jeffrey A, Shanahan E Micha |
Functional polymorphisms of the ABCG2 gene are associated with gout disease in the Chinese Han male population. International journal of molecular sciences 2014 15 (5): 9149-59. Zhou Danqiu, Liu Yunqing, Zhang Xinju, Gu Xiaoye, Wang Hua, Luo Xinhua, Zhang Jin, Zou Hejian, Guan Mi |
Common variant of ALPK1 is not associated with gout: a replication study. Human cell 2015 Jan 28 (1): 1-4. Chiba Toshinori, Matsuo Hirotaka, Sakiyama Masayuki, Nakayama Akiyoshi, Shimizu Seiko, Wakai Kenji, Suma Shino, Nakashima Hiroshi, Sakurai Yutaka, Shimizu Toru, Ichida Kimiyoshi, Shinomiya Nariyos |
Pharmacogenomics of NAT2 and ABCG2 influence the toxicity and efficacy of sulphasalazine containing DMARD regimens in early rheumatoid arthritis. The pharmacogenomics journal 2014 Aug 14 (4): 350-5. Wiese M D, Alotaibi N, O'Doherty C, Sorich M J, Suppiah V, Cleland L G, Proudman S |
Semiphysiologically Based Pharmacokinetic Model of Leflunomide Disposition in Rheumatoid Arthritis Patients. CPT: pharmacometrics & systems pharmacology 2015 Jun 4 (6): 362-71. Hopkins A M, Wiese M D, Proudman S M, O'Doherty C E, Foster Djr, Upton R |
Genetic variation in the ABCG2 gene is associated with gout risk in the Chinese Han population. Clinical rheumatology 2015 Oct . Jiri Mutu, Zhang Le, Lan Bing, He Na, Feng Tian, Liu Kai, Jin Tianbo, Kang Long |
Clinical-pharmacogenetic predictive models for MTX discontinuation due to adverse events in rheumatoid arthritis. The pharmacogenomics journal 2016 May . Jenko B, Lusa L, Tomsic M, Praprotnik S, Dolzan |
Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population. Journal of pharmaceutical health care and sciences 2016 2 35. Hashiguchi Masayuki, Shimizu Mikiko, Hakamata Jun, Tsuru Tomomi, Tanaka Takanori, Suzaki Midori, Miyawaki Kumika, Chiyoda Takeshi, Takeuchi Osamu, Hiratsuka Jiro, Irie Shin, Maruyama Junya, Mochizuki Mayu |
Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis. The Journal of rheumatology 2017 Jun . Zajc Avramovi? Mojca, Dolžan Vita, Toplak Nataša, Accetto Meta, Lusa Lara, Av?in Tad |
Effects of multiple genetic loci on the pathogenesis from serum urate to gout. Scientific reports 2017 Mar 7 43614. Dong Zheng, Zhou Jingru, Jiang Shuai, Li Yuan, Zhao Dongbao, Yang Chengde, Ma Yanyun, Wang Yi, He Hongjun, Ji Hengdong, Yang Yajun, Wang Xiaofeng, Xu Xia, Pang Yafei, Zou Hejian, Jin Li, Wang Jiuc |
Genetic predictors of efficacy and toxicity of iguratimod in patients with rheumatoid arthritis. Pharmacogenomics 2018 Mar . Xiao Wenjing, Guo Jian-Ping, Li Chun, Ye Hua, Wei Wei, Zou Yaohong, Dai Lie, Li Zhijun, Zhang Miaojia, Li Xiangpei, Cai Xiaoyan, Zhao Jianhong, Wang Youlian, Tao Yi, Liu Dongzhou, Li Yasong, Wu Min, Sun Erwei, Wu Lijun, Luo Li, Mu Rong, Li Zhang |
Genetic polymorphism of the methotrexate transporter ABCG2, blood pressure and markers of arterial function in patients with rheumatoid arthritis: repeated cross-sectional study. Pharmacogenomics and personalized medicine 2018 11 205-210. Baghdadi Leena R, Woodman Richard J, Shanahan E Michael, Wiese Michael D, Mangoni Arduino |
ABCG2 gene polymorphism rs2231142 is associated with gout comorbidities but not allopurinol response in primary gout patients of a Chinese Han male population. Hereditas 2019 156 26. Zhang Keke, Li Changg |
A population pharmacokinetic study to accelerate early phase clinical development for a novel drug, teriflunomide sodium, to treat systemic lupus erythematosus. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2019 6 136 104942. Yao Xueting, Wu Yiwen, Jiang Ji, Chen Xia, Liu Dongyang, Hu P |
Interaction of the p.Q141K Variant of the ABCG2 Gene with Clinical Data and Cytokine Levels in Primary Hyperuricemia and Gout. Journal of clinical medicine 2019 Nov 8 (11): . Horváthová Veronika, Bohatá Jana, Pavlíková Markéta, Pavelcová Kate?ina, Pavelka Karel, Šenolt Ladislav, Stib?rková Blan |
Polymorphisms of ABCG2 and SLC22A12 Genes Associated with Gout Risk in Vietnamese Population. Medicina (Kaunas, Lithuania) 2019 1 55 (1): . Duong Nguyen Thuy, Ngoc Nguyen Thy, Thang Nguyen Tran Minh, Phuong Bach Thi Hoai, Nga Nguyen Thanh, Tinh Nguyen Doan, Quynh Do Hai, Ton Nguyen Dang, Hai Nong V |
Clinical and Laboratory Associations with Methotrexate Metabolism Gene Polymorphisms in Rheumatoid Arthritis. Journal of personalized medicine 2020 9 10 (4): . D'Cruz Leon G, McEleney Kevin G, Tan Kyle B C, Shukla Priyank, Gardiner Philip V, Connolly Patricia, Conway Caroline, Cobice Diego, Gibson David |
Frequency and impact of DHODH, ABCG2 and CYP2C19 SNPs on the therapeutic efficacy, tolerability and toxicity of leflunomide. Pharmacogenomics 2021 11 22 (18): 1201-1209. Makarem Yasmine S, Hareedy Mohammad Salem, Hassanien Manal, Ahmed Esraa A, Hetta Helal F, Mohamed Alaa |
Dutch pharmacogenetics working group guideline for the gene-drug interaction of ABCG2, HLA-B and Allopurinol, and MTHFR, folic acid and methotrexate. European journal of human genetics : EJHG 2022 9 . van der Pol Karel H, Nijenhuis Marga, Soree Bianca, de Boer-Veger Nienke J, Buunk Anne Marie, Guchelaar Henk-Jan, Risselada Arne, van Schaik Ron H N, Swen Jesse J, Touw Daan, van der Weide Jan, van Westrhenen Roos, Deneer Vera H M, Houwink Elisa J F, Rongen Gerard |
Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia. Clinical and experimental medicine 2022 Aug . Pálinkás Márton, Szabó Edit, Kulin Anna, Mózner Orsolya, Rásonyi Rita, Juhász Péter, Nagy Krisztina, Várady György, Vörös Dóra, Zámbó Boglárka, Sarkadi Balázs, Poór Gyu |
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report. Pharmacogenomics and personalized medicine 2022 5 15 465-475. Jeiziner Chiara, Allemann Samuel S, Hersberger Kurt E, Meyer Zu Schwabedissen Henriette |
Associations Between Genetic Polymorphisms Within Transporter Genes and Clinical Response to Methotrexate in Chinese Rheumatoid Arthritis Patients: A Pilot Study. Pharmacogenomics and personalized medicine 2022 4 15 327-339. Cen Han, Wen Qin-Wen, Zhang Han-Qing, Yu Hang, Zeng Zhen, Jin Ting, Wang Ting-Hui, Qin Wen, Huang Hua, Wu Xiu- |
Single-nucleotide polymorphisms link gout with health-related lifestyle factors in Korean cohorts. PloS one 2023 12 18 (12): e0295038. Hye Kyung Jeon, Hae Young Y |
Novel genetic loci in early-onset?gout derived from whole genome sequencing of an adolescent gout cohort. Arthritis & rheumatology (Hoboken, N.J.) 2024 8 . Aichang Ji, Yang Sui, Xiaomei Xue, Xiaopeng Ji, Wenrui Shi, Yongyong Shi, Robert Terkeltaub, Nicola Dalbeth, Riku Takei, Fei Yan, Mingshu Sun, Maichao Li, Jie Lu, Lingling Cui, Zhen Liu, Can Wang, Xinde Li, Lin Han, Zhanjie Fang, Wenyan Sun, Yue Liang, Yuwei He, Guangmin Zheng, Xuefeng Wang, Jiayi Wang, Hui Zhang, Lei Pang, Han Qi, Yushuang Li, Zan Cheng, Zhiqiang Li, Jingfa Xiao, Changqing Zeng, Tony R Merriman, Hongzhu Qu, Xiangdong Fang, Changgui |
- Page last reviewed:Feb 1, 2024
- Content source: